ChromaDex (CDXC)
(Delayed Data from NSDQ)
$3.17 USD
+0.01 (0.32%)
Updated May 22, 2024 03:59 PM ET
After-Market: $3.20 +0.03 (0.95%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum B VGM
Brokerage Reports
ChromaDex Corporation [CDXC]
Reports for Purchase
Showing records 101 - 112 ( 112 total )
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
We are initiating coverage with a Buy rating and a 12-month price target of $6.00.
Provider: Rodman & Renshaw, Co.
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
We are initiating coverage with a Buy rating and a 12-month price target of $6.00.
Provider: H.C. Wainwright & Co., Inc.
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
We are terminating research coverage due to the termination or loss of the primary and/or secondary analysts responsible for coverage.
Provider: DAWSON JAMES SECURITIES, INC.
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Chromadex provides products and services to the natural foods industry
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
BluScienceTM Products in Walgreens, GNCBluScienceTM Initial Advertising Campaign Launched
Provider: REDCHIP
Analyst: PFISTER T
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Announced Common Stock Sale Consummated New Investment Acquired from OPKO Health, Inc
Provider: REDCHIP
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Initiating coverage with a 12-month price target of $2.20 and rating of STRONG BUY.
Provider: REDCHIP
Analyst: RESNIK P
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
New distribution & development partners pave the way for growth in 2011
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
INITIATION REPORT
Provider: DAWSON JAMES SECURITIES, INC.